Scholarlink

<p>Antimicrobial resistance (AMR) represents one of the major threats to global public health, particularly in hospital settings. Among the most concerning pathogens are carbapenemase-producing <i>Enterobacterales</i> (CPE), which compromise the effectiveness of last-line antibiotics such as meropenem. This study aimed to analyze the prevalence of carbapenemase production among <i>Enterobacterales</i> classified as resistant or susceptible, increased exposure to meropenem at the Hospital de Clínicas de Porto Alegre (HCPA) between 2019 and 2024. This descriptive, retrospective study was based on laboratory data obtained through a structured query of the microbiology database, without access to clinical or identifiable patient information. Carbapenemase detection was performed using the NG-Test<sup>®</sup> Carba 5 and high-resolution melting quantitative polymerase chain reaction (HRM-qPCR). Data were anonymized and analyzed using absolute and relative frequencies. Temporal analysis revealed a shift in the carbapenememase profile over the study period, characterized by a progressive decline in KPC-producing isolates in the post-pandemic years and a concomitant increase in NDM-producing <i>Enterobacterales</i>, indicating a significant epidemiological change. This study contributes to understanding the evolving epidemiology of CPE and supports improved surveillance and clinical management strategies in the context of AMR.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Prevalence of carbapenemase production among Enterobacterales with reduced susceptibility to meropenem in patients at Hospital de Clínicas de Porto Alegre (HCPA) between 2019 and 2024

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月1日

查看全文
  • Eduarda Lanzoni Filter,
  • Mariana Preussler Mott,
  • Karine Rigon Zimmer,
  • Denise Pires Machado,
  • Larissa Lutz,
  • Caroline Constante,
  • Rodrigo Minuto Paiva

摘要

Antimicrobial resistance (AMR) represents one of the major threats to global public health, particularly in hospital settings. Among the most concerning pathogens are carbapenemase-producing Enterobacterales (CPE), which compromise the effectiveness of last-line antibiotics such as meropenem. This study aimed to analyze the prevalence of carbapenemase production among Enterobacterales classified as resistant or susceptible, increased exposure to meropenem at the Hospital de Clínicas de Porto Alegre (HCPA) between 2019 and 2024. This descriptive, retrospective study was based on laboratory data obtained through a structured query of the microbiology database, without access to clinical or identifiable patient information. Carbapenemase detection was performed using the NG-Test® Carba 5 and high-resolution melting quantitative polymerase chain reaction (HRM-qPCR). Data were anonymized and analyzed using absolute and relative frequencies. Temporal analysis revealed a shift in the carbapenememase profile over the study period, characterized by a progressive decline in KPC-producing isolates in the post-pandemic years and a concomitant increase in NDM-producing Enterobacterales, indicating a significant epidemiological change. This study contributes to understanding the evolving epidemiology of CPE and supports improved surveillance and clinical management strategies in the context of AMR.